Logothetis Astellas <10K <10K Christopher BMS <10K <10K J + J <10K <10K Excelixir <10K <10K Novartis <10K <10K Pfizer <10K <10K Fernando None Morgans Alicia Genentech 10-50K <10K Bayer <10K <10K Dendreon <10K <10K Morris Michael Tokai <10K Bayer Institutional <10K conctracts for clinical trials (no direct funding) See above Endocyte See above Sanofi Mottet Nicolas Takeda <10K <10K pharmaceutical/Millenium Astellas <20K <10K <10K Pierre Fabre <10K Sanofi <20K <10K Janssen < 20k <20K Nuclétron <10K Bayer <10K Ipsen <10K <10K Ferring <10K Murthy Vedang None Oh William None Aurelius Astellas <10K (institut.) <10K Bayer <10K(institut.) <10K Janssen <10K (institut.) >50K (institut.) <10K Sanofi <10K (institut.) <10K Teva 10-50K (institut.)
Logothetis Christopher Astellas BMS J + J Excelixir Novartis Pfizer <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K <10K Fernando None Morgans Alicia Genentech Bayer Dendreon 10-50K <10K <10K <10K <10K <10K Morris Michael Tokai Bayer Endocyte Sanofi <10K Institutional conctracts for clinical trials (no direct funding) See above See above <10K Mottet Nicolas Takeda pharmaceutical/Millenium Astellas Pierre Fabre Sanofi Janssen Nuclétron Bayer Ipsen Ferring <10K <20K <20K < 20k <10K <10K <10K <10K <10K <10K <10K <10K <10K <20K <10K Murthy Vedang None Oh William None Aurelius Astellas Bayer Janssen Sanofi Teva <10K (institut.) <10K(institut.) <10K (institut.) <10K (institut.) >50K (institut.) 10-50K (institut.) <10K <10K <10K <10K